New imaging technique could let doctors see lung Cancer's inner workings in real time
NCT ID NCT02676050
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested whether two optical imaging agents could be used during a bronchoscopy to visualize activated neutrophils and a cancer-related protein called c-MET in lung tumors. Five participants with lung cancer received the agents through a special catheter while doctors used a miniaturized imaging fiber to detect signals. The goal was to explore whether this technique could provide real-time molecular insights into lung cancer, but the study was terminated early and was not designed to treat the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Optical imaging agents (EMI-137 and NAP)
- What this could lead to
- If successful, this approach could help doctors see specific cancer-related molecules in real time during a lung exam, potentially improving diagnosis or treatment guidance.
- What could go wrong
- This was a very small, early exploratory study that was terminated early. It was designed only to test imaging feasibility, not to treat or cure lung cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Infirmary of Edinburgh
Edinburgh, EH16 4TJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection